Details for New Drug Application (NDA): 078957
✉ Email this page to a colleague
The generic ingredient in STAVUDINE is stavudine. There are fourteen drug master file entries for this compound. Additional details are available on the stavudine profile page.
Summary for 078957
Tradename: | STAVUDINE |
Applicant: | Hetero Labs Ltd Iii |
Ingredient: | stavudine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 078957
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 15MG | ||||
Approval Date: | Dec 29, 2008 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
Approval Date: | Dec 29, 2008 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 30MG | ||||
Approval Date: | Dec 29, 2008 | TE: | RLD: | No |
Complete Access Available with Subscription